iohexol has been researched along with Seizures in 13 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To establish the incidence of and risk factors for seizures following myelography performed with iohexol in dogs." | 7.77 | Incidence of and risk factors for seizures after myelography performed with iohexol in dogs: 503 cases (2002-2004). ( da Costa, RC; Dobson, H; Parent, JM, 2011) |
| "To determine prevalence of seizures after use of iohexol for myelography and identify associated risk factors in dogs." | 7.71 | Risk factors associated with development of seizures after use of iohexol for myelography in dogs: 182 cases (1998). ( Barone, G; Shofer, FS; Steinberg, SA; Ziemer, LS, 2002) |
| "To establish the incidence of and risk factors for seizures following myelography performed with iohexol in dogs." | 3.77 | Incidence of and risk factors for seizures after myelography performed with iohexol in dogs: 503 cases (2002-2004). ( da Costa, RC; Dobson, H; Parent, JM, 2011) |
| "To determine prevalence of seizures after use of iohexol for myelography and identify associated risk factors in dogs." | 3.71 | Risk factors associated with development of seizures after use of iohexol for myelography in dogs: 182 cases (1998). ( Barone, G; Shofer, FS; Steinberg, SA; Ziemer, LS, 2002) |
| "Documentation of main adverse effects, their magnitudes and relationship to contrast concentrations in patients subjected to myelography under basic radiographic facilities." | 2.68 | Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects. ( Kazema, RR; Ndosi, BN; Ndosi, NK, 1996) |
| "Contrast-induced encephalopathy (CIE) is a rare complication of angiography." | 1.48 | Contrast-induced encephalopathy after percutaneous peripheral intervention. ( Ağca, M; Çakmak, EÖ; Geçmen, Ç; İzgi, İA; Kahyaoğlu, M, 2018) |
| "Iotrolan induced generalized seizures in 5 rabbits, iodixanol 320 mg I/ml in 2 rabbits, and iodixanol 150 mg I/ml in one rabbit." | 1.29 | CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit. ( Bååth, L; Maly, P; Sundgren, P, 1995) |
| "Seizures were significantly more prevalent when body weight was greater than or equal to 29 kg (P less than 0." | 1.28 | Complications associated with the use of iohexol for myelography of the cervical vertebral column in dogs: 66 cases (1988-1990). ( Hosgood, G; Lewis, DD, 1992) |
| "Selective left vertebral angiography was carried out in 25 rabbits comparing the toxic effects of iohexol and metrizamide (Amipaque)." | 1.26 | The toxicity of the non-ionic water-soluble contrast media iohexol and metrizamide (Amipaque) in selective vertebral angiography. An experimental study in rabbits. ( Skalpe, IO, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahyaoğlu, M | 1 |
| Ağca, M | 1 |
| Çakmak, EÖ | 1 |
| Geçmen, Ç | 1 |
| İzgi, İA | 1 |
| da Costa, RC | 1 |
| Parent, JM | 1 |
| Dobson, H | 1 |
| Golman, K | 2 |
| Olivecrona, H | 2 |
| Gustafson, C | 1 |
| Salvesen, S | 1 |
| Almén, T | 2 |
| Maly, P | 4 |
| Skalpe, IO | 1 |
| Idée, JM | 1 |
| Hartl, C | 1 |
| Santus, R | 1 |
| Doucet, D | 1 |
| Bonnemain, B | 1 |
| Sundgren, P | 2 |
| Bååth, L | 2 |
| Kisara, K | 1 |
| Sakurada, S | 1 |
| Tadano, T | 1 |
| Sakurada, T | 1 |
| Tan-No, K | 1 |
| Usui, C | 1 |
| Kitano, Y | 1 |
| Takasuna, K | 1 |
| Ndosi, BN | 1 |
| Ndosi, NK | 1 |
| Kazema, RR | 1 |
| Barone, G | 1 |
| Ziemer, LS | 1 |
| Shofer, FS | 1 |
| Steinberg, SA | 1 |
| Lewis, DD | 1 |
| Hosgood, G | 1 |
| Dalen, K | 1 |
| Kerr, HH | 1 |
| Wang, AM | 1 |
| Olson, RE | 1 |
| Wesolowski, DP | 1 |
| Farah, J | 1 |
1 trial available for iohexol and Seizures
| Article | Year |
|---|---|
Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
Topics: Adolescent; Adult; Aged; Child; Contrast Media; Dizziness; Double-Blind Method; Female; Headache; Hu | 1996 |
12 other studies available for iohexol and Seizures
| Article | Year |
|---|---|
Contrast-induced encephalopathy after percutaneous peripheral intervention.
Topics: Aged; Angiography; Blindness; Brain Diseases; Contrast Media; Humans; Iohexol; Male; Peripheral Arte | 2018 |
Incidence of and risk factors for seizures after myelography performed with iohexol in dogs: 503 cases (2002-2004).
Topics: Animals; Contrast Media; Dog Diseases; Dogs; Female; Hallucinations; Iohexol; Male; Myelography; Ret | 2011 |
Excitation and depression of non-anaesthetized rabbits following injection of contrast media into the subarachnoid space.
Topics: Animals; Brain; Contrast Media; Depression, Chemical; Dose-Response Relationship, Drug; Injections, | 1980 |
Excitative effects in anaesthetized rabbits from subarachnoidally injected iso- and hyperosmolar solutions of iohexol and metrizamide.
Topics: Anesthesia; Animals; Contrast Media; Female; Injections; Iodobenzoates; Iohexol; Male; Metrizamide; | 1984 |
The toxicity of the non-ionic water-soluble contrast media iohexol and metrizamide (Amipaque) in selective vertebral angiography. An experimental study in rabbits.
Topics: Animals; Bradycardia; Contrast Media; Female; Iodobenzoates; Iohexol; Male; Metrizamide; Paralysis; | 1981 |
[Electrocorticographic evaluation of the neurologic tolerability of iobitridol (Xenetix), a new non-ionic contrast medium in rabbits].
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Diatrizoate; Electroencephalography; Extravasat | 1995 |
CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit.
Topics: Akathisia, Drug-Induced; Animals; Behavior, Animal; Brain; Calcium Chloride; Contrast Media; Depress | 1995 |
[Central effects of iohexol and iopamidol, non-ionic contrast media].
Topics: Animals; Body Temperature; Contrast Media; Electroencephalography; Electroshock; Iohexol; Iopamidol; | 1993 |
Neural tolerability of commercial preparations of iodinated nonionic monomers and dimers: comparison in an animal model.
Topics: Animals; Behavior, Animal; Brain; Contrast Media; Dose-Response Relationship, Drug; Injections; Iohe | 1996 |
Risk factors associated with development of seizures after use of iohexol for myelography in dogs: 182 cases (1998).
Topics: Animals; Body Weight; Contrast Media; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; | 2002 |
Complications associated with the use of iohexol for myelography of the cervical vertebral column in dogs: 66 cases (1988-1990).
Topics: Anesthesia, General; Animals; Breeding; Dog Diseases; Dogs; Female; Iohexol; Male; Myelography; Prea | 1992 |
Seizure activity after iohexol myelography.
Topics: Female; Humans; Iohexol; Middle Aged; Myelography; Seizures; Spinal Puncture | 1991 |